CP-154,526 is a potent and selective antagonist of the corticotropin releasing hormone receptor 1 developed by Pfizer. CP-154,526 is under investigation for the…
CP-154,526 is a potent and selective antagonist of the corticotropin releasing hormone receptor 1 developed by Pfizer.
CP-154,526 is under investigation for the potential treatment of alcoholism.
See also Antalarmin Pexacerfont Corticotropin releasing hormone antagonist
References
Further reading
External links
Gebaseerd op: Wikipedia — CP-154,526 · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.